Background In hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia,
progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is …

Background An unprecedented global monkeypox outbreak started in May, 2022. No data
are yet available about the dynamics of the immune response against monkeypox virus. The …

Introduction Several recent case reports have described common early chest imaging findings
of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be …

It is estimated that globally there are approximately 100 million persons with serological
evidence of current or past HCV infection, and that HCV causes about 700 000 deaths each year…

Background Data on SARS-CoV-2 vaccine immunogenicity in PLWH are currently limited.
Aim of the study was to investigate immunogenicity according to current CD4 T-cell count …

Viral hepatitis is a major global public health problem (Fig. 1) affecting hundreds of millions
of people and is associated with significant morbidity and mortality (Fig. 2). Five biologically …

Background and Objective Pseudomonas aeruginosa infection represents a main cause of
morbidity and mortality among immunocompromised patients. This study describes a fatal …

BACKGROUND. Infection with Ebola virus (EBOV) results in a life-threatening disease, with
reported mortality rates between 50%–70%. The factors that determine patient survival are …

Data concerning the transmission of the novel severe acute respiratory syndrome
coronavirus (SARS-CoV-2) in paucisymptomatic patients are lacking. We report an Italian …

Background Detailed temporal analyses of complete (full) blood count (CBC) parameters,
their evolution and relationship to patient age, gender, co-morbidities and management …